Literature DB >> 12767497

The prevalence and clinical characteristics of MS in northern Japan.

Hideki Houzen1, Masaaki Niino, Seiji Kikuchi, Toshiyuki Fukazawa, Shinji Nogoshi, Hiroyuki Matsumoto, Kunio Tashiro.   

Abstract

In Japan, there is a low prevalence rate (PR) of multiple sclerosis (MS; 0.8-4.0/100,000) but a relatively high frequency of "optic-spinal form" MS (OS-MS). There have been no intensive epidemiologic frequency studies, however, in over 30 years. We performed a province-wide prevalence study of MS in the Tokachi province of Hokkaido, the northernmost island of Japan, and compared the observed clinical features with other populations in Japan and Western countries. Prevalence was determined on March 31, 2001. The primary sources for the case ascertainment were 13 hospitals that treated patients with neurologic diseases including MS in Tokachi. Patients were classified according to Poser's criteria. The prevalence rate of clinically definite or laboratory-supported definite MS (LSDMS) was 8.57 per 100,000 [31/361,726; male/female ratio=1:2.9, and age at onset=29.1+/-14.2 (mean+/-SD) years]. Out of the 31 patients, 5 (16%) were classified as OS-MS. The prevalence rate of MS in the Tokachi province was the highest reported in Orientals to date, although still low in comparison with Western communities at a similar latitude. In contrast to the previous reports in Japan, there was a relatively low frequency of OS-MS in Hokkaido.

Entities:  

Mesh:

Year:  2003        PMID: 12767497     DOI: 10.1016/s0022-510x(03)00033-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

Review 1.  Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics.

Authors:  DeRen Huang
Journal:  Neurosci Bull       Date:  2015-12       Impact factor: 5.203

2.  Preliminary studies on the clinical features of multiple sclerosis in Korea.

Authors:  Sang-Soo Lee; Eun-Hee Sohn; Seon-Woo Nam
Journal:  J Clin Neurol       Date:  2006-12-20       Impact factor: 3.077

Review 3.  Pediatric multiple sclerosis.

Authors:  Brenda L Banwell
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

4.  Multiple sclerosis in Japan appears to be a milder disease compared to the UK.

Authors:  L Piccolo; G Kumar; I Nakashima; T Misu; Y Kong; B Wakerley; S Ryan; A Cavey; K Fujihara; Jacqueline Palace
Journal:  J Neurol       Date:  2015-01-22       Impact factor: 4.849

5.  Multiple Sclerosis in the Asia Pacific Region: A Systematic Review of a Neglected Neurological Disease.

Authors:  Wing L Cheong; Devi Mohan; Narelle Warren; Daniel D Reidpath
Journal:  Front Neurol       Date:  2018-06-08       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.